|
1
|
Lau T, Carlsson PO and Leung PS: Evidence
for a local angiotensin-generating system and dose-dependent
inhibition of glucose-stimulated insulin release by angiotensin II
in isolated pancreatic islets. Diabetologia. 47:240–248. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Favre GA, Esnault VL and Van Obberghen E:
Modulation of glucose metabolism by the
renin-angiotensin-aldosterone system. Am J Physiol Endocrinol
Metab. 308:E435–E449. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ko SH, Kwon HS, Kim SR, Moon SD, Ahn YB,
Song KH, Son HS, Cha BY, Lee KW, Son HY, et al: Ramipril treatment
suppresses islet fibrosis in otsuka long-evans tokushima fatty
rats. Biochem Biophys Res Commun. 316:114–122. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nakayama M, Inoguchi T, Sonta T, Maeda Y,
Sasaki S, Sawada F, Tsubouchi H, Sonoda N, Kobayashi K, Sumimoto H
and Nawata H: Increased expression of NAD (P)H oxidase in islets of
animal models of Type 2 diabetes and its improvement by an AT1
receptor antagonist. Biochem Biophys Res Commun. 332:927–933. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tikellis C, Wookey PJ, Candido R,
Andrikopoulos S, Thomas MC and Cooper ME: Improved islet morphology
after blockade of the renin-angiotensin system in the ZDF rat.
Diabetes. 53:989–997. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cheng Q, Law PK, de Gasparo M and Leung
PS: Combination of the dipeptidyl peptidase IV inhibitor LAF237
[(S)-1-[(3-hydroxy-1-adamantyl)ammo]acetyl-2-cyanopyrrolidine] with
the angiotensin II type 1 receptor antagonist valsartan
[N-(1-oxopentyl)-N-[[2′-(1H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl]
methyl]-L-valine] enhances pancreatic islet morphology and function
in a mouse model of type 2 diabetes. J Pharmacol Exp Ther.
327:683–691. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Frantz ED, Crespo-Mascarenhas C,
Barreto-Vianna AR, Aguila MB and Mandarim-de-Lacerda CA:
Renin-angiotensin system blockers protect pancreatic islets against
diet-induced obesity and insulin resistance in mice. PLoS One.
8:e671922013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Braga MF and Leiter LA: Role of
renin-angiotensin system blockade in patients with diabetes
mellitus. Am J Cardiol. 104:835–839. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Scheen AJ: Renin-angiotensin system
inhibition prevents type 2 diabetes mellitus. Part 1. A
meta-analysis of randomised clinical trials. Diabetes Metab.
30:487–496. 2004. View Article : Google Scholar
|
|
10
|
Scheen AJ: Renin-angiotensin system
inhibition prevents type 2 diabetes mellitus. Part 2. Overview of
physiological and biochemical mechanisms. Diabetes Metab.
30:498–505. 2004. View Article : Google Scholar
|
|
11
|
Califf RM, Boolell M, Haffner SM, Bethel
M, McMurray J, Duggal A and Holman RR; NAVIGATOR Study Group:
Prevention of diabetes and cardiovascular disease in patients with
impaired glucose tolerance: Rationale and design of the nateglinide
and valsartan in impaired glucose tolerance outcomes research
(NAVIGATOR) Trial. Am Heart J. 156:623–632. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang JK, Feng Y, Yuan MY, Yuan SY, Fu HJ,
Wu BY, Sun GZ, Yang GR, Zhang XL, Wang L, et al: Plasma glucose
levels and diabetes are independent predictors for mortality and
morbidity in patients with SARS. Diabet Med. 23:623–628. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li W, Moore MJ, Vasilieva N, Sui J, Wong
SK, Berne MA, Somasundaran M, Sullivan JL, Luzuriaga K, Greenough
TC, et al: Angiotensin-converting enzyme 2 is a functional receptor
for the SARS coronavirus. Nature. 426:450–454. 2003. View Article : Google Scholar
|
|
14
|
Niu MJ, Yang JK, Lin SS, Ji XJ and Guo LM:
Loss of angiotensin-converting enzyme 2 leads to impaired glucose
homeostasis in mice. Endocrine. 34:56–61. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bindom SM, Hans CP, Xia H, Boulares AH and
Lazartigues E: Angiotensin I-converting enzyme type 2 (ACE2) gene
therapy improves glycemic control in diabetic mice. Diabetes.
59:2540–2548. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Benter IF, Yousif MH, Cojocel C,
Al-Maghrebi M and Diz DI: Angiotensin-1-7 prevents diabetes-induced
cardiovascular dysfunction. Am J Physiol Heart Circ Physiol.
292:H666–H672. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xia H, Suda S, Bindom S, Feng Y, Gurley
SB, Seth D, Navar LG and Lazartigues E: ACE2-mediated reduction of
oxidative stress in the central nervous system is associated with
improvement of autonomic function. PLoS One. 6:e226822011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dhaunsi GS, Yousif MH, Akhtar S, Chappell
MC, Diz DI and Benter IF: Angiotensin-1-7 prevents diabetes-induced
attenuation in PPAR-gamma and catalase activities. Eur J Pharmacol.
638:108–114. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xue B, Zhang Z, Beltz TG, Guo F, Hay M and
Johnson AK: Estrogen regulation of the brain renin-angiotensin
system in protection against angiotensin II-induced sensitization
of hypertension. Am J Physiol Heart Circ Physiol. 307:H191–H198.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Drews G, Krippeit-Drews P and Düfer M:
Oxidative stress and beta-cell dysfunction. Pflugers Arch.
460:703–718. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dikalov SI and Nazarewicz RR: Angiotensin
II-induced production of mitochondrial reactive oxygen species:
Potential mechanisms and relevance for cardiovascular disease.
Antioxid Redox Signal. 19:1085–1094. 2013. View Article : Google Scholar :
|
|
22
|
Pi J, Bai Y, Zhang Q, Wong V, Floering LM,
Daniel K, Reece JM, Deeney JT, Andersen ME, Corkey BE and Collins
S: Reactive oxygen species as a signal in glucose-stimulated
insulin secretion. Diabetes. 56:1783–1791. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Robertson RP: Chronic oxidative stress as
a central mechanism for glucose toxicity in pancreatic islet beta
cells in diabetes. J Biol Chem. 279:42351–42354. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Giani JF, Mayer MA, Muñoz MC, Silberman
EA, Höcht C, Taira CA, Gironacci MM, Turyn D and Dominici FP:
Chronic infusion of angiotensin-1-7 improves insulin resistance and
hypertension induced by a high-fructose diet in rats. Am J Physiol
Endocrinol Metab. 296:E262–E271. 2009. View Article : Google Scholar
|
|
25
|
Santos SH, Fernandes LR, Mario EG,
Ferreira AV, Pôrto LC, Alvarez-Leite JI, Botion LM, Bader M,
Alenina N and Santos RA: Mas deficiency in FVB/N mice produces
marked changes in lipid and glycemic metabolism. Diabetes.
57:340–347. 2008. View Article : Google Scholar
|
|
26
|
Satin LS: Localized calcium influx in
pancreatic beta-cells: Its significance for
Ca2+-dependent insulin secretion from the islets of
Langerhans. Endocrine. 13:251–262. 2000. View Article : Google Scholar
|
|
27
|
Carter JD, Dula SB, Corbin KL, Wu R and
Nunemaker CS: A practical guide to rodent islet isolation and
assessment. Biol Proced Online. 11:3–31. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Matschinsky FM, Magnuson MA, Zelent D,
Jetton TL, Doliba N, Han Y, Taub R and Grimsby J: The network of
glucokinase-expressing cells in glucose homeostasis and the
potential of glucokinase activators for diabetes therapy. Diabetes.
55:1–12. 2006. View Article : Google Scholar
|
|
29
|
Silva JP, Köhler M, Graff C, Oldfors A,
Magnuson MA, Berggren PO and Larsson NG: Impaired insulin secretion
and beta-cell loss in tissue-specific knockout mice with
mitochondrial diabetes. Nat Genet. 26:336–340. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Maassen JA, 'T Hart LM, Van Essen E, Heine
RJ, Nijpels G, Jahangir Tafrechi RS, Raap AK, Janssen GM and Lemkes
HH: Mitochondrial diabetes: Molecular mechanisms and clinical
presentation. Diabetes. 53(Suppl 1): S103–S109. 2004. View Article : Google Scholar : PubMed/NCBI
|
